Sandbox MWH: Difference between revisions
No edit summary |
No edit summary |
||
Line 21: | Line 21: | ||
* First-ever use of amphetamines in the treatment of narcolepsy | * First-ever use of amphetamines in the treatment of narcolepsy | ||
|- | |- | ||
! style="background: #DCDCDC; text-align: center;" |''' | ! style="background: #DCDCDC; text-align: center;" |'''1960''' | ||
| style="background: #F5F5F5;" | | | style="background: #F5F5F5;" | | ||
* | * Description of Sleep Onset REM in patients with narcolepsy | ||
|- | |- | ||
! style="background: #DCDCDC; text-align: center;" |''' | ! style="background: #DCDCDC; text-align: center;" |'''1970''' | ||
| style="background: #F5F5F5;" | | | style="background: #F5F5F5;" | | ||
* | * Multiple Latency Test description | ||
|- | |- | ||
! style="background: #DCDCDC; text-align: center;" |''' | ! style="background: #DCDCDC; text-align: center;" |'''1973''' | ||
| style="background: #F5F5F5;" | | | style="background: #F5F5F5;" | | ||
* First-ever | * First-ever report of narcolepsy in a canine | ||
|- | |- | ||
! style="background: #DCDCDC; text-align: center;" |''' | ! style="background: #DCDCDC; text-align: center;" |'''1983''' | ||
| style="background: #F5F5F5;" | | | style="background: #F5F5F5;" | | ||
* | * Association of HLA-DR2 with narcolepsy | ||
|- | |- | ||
! style="background: #DCDCDC; text-align: center;" |''' | ! style="background: #DCDCDC; text-align: center;" |'''1992''' | ||
| style="background: #F5F5F5;" | | | style="background: #F5F5F5;" | | ||
* | * Association of HLA-DQB1*0602 with narcolepsy | ||
|- | |- | ||
! style="background: #DCDCDC; text-align: center;" |''' | ! style="background: #DCDCDC; text-align: center;" |'''1998''' | ||
| style="background: #F5F5F5;" | | | style="background: #F5F5F5;" | | ||
* | * Hypocretins (orexins) and their receptors identification | ||
|- | |- | ||
! style="background: #DCDCDC; text-align: center;" | | ! style="background: #DCDCDC; text-align: center;" |2000 | ||
| style="background: #F5F5F5;" | | | style="background: #F5F5F5;" | | ||
* | * Association between Human narcolepsy and hypocretin deficiency | ||
|} | |} | ||
Revision as of 16:12, 14 August 2020
Year | Discovery |
---|---|
1877 |
|
1880 |
|
1902 |
|
1935 |
|
1960 |
|
1970 |
|
1973 |
|
1983 |
|
1992 |
|
1998 |
|
2000 |
|
Table 1: A few milestones in narcolepsy research and therapy
1877 First description in the medical literature (100)
1880 Gelineau called the disorder “narcolepsy” (28)
1902 Loewenfeld coined the term “cataplexy” (53)
1935 First use of amphetamines in the treatment of narcolepsy (87)
1960 Description of Sleep Onset REM periods in a narcoleptic subject (99)
1970 Description of the Multiple Latency Test (15, 90)
1973 First report of a narcoleptic dog (47, 72)
1983 Association of narcolepsy with HLA-DR2 (37)
1985 Monoaminergic and cholinergic imbalance in narcolepsy (7, 80)
1992 Association of narcolepsy with HLA-DQB1*0602 (56, 63)
1998 Identification of hypocretins/orexins and their receptors (18, 93)
1999 Hypocretin mutations cause narcolepsy in mice and dogs (16, 51)
2000 Human narcolepsy is also associated with an hypocretin deficiency (81)